The Daily Pennsylvanian is a student-run nonprofit.

Please support us by disabling your ad blocker on our site.

Carl June was awarded for his work with chimeric antigen receptor (CAR) T-cell therapy, the first U.S. FDA-approved personalized cellular therapy for cancer.